Loading organizations...
Cadence provides remote patient monitoring solutions for chronic disease management. Its platform integrates advanced technology with clinical support, delivering proactive, personalized care. This approach improves patient health outcomes and boosts operational efficiency for healthcare systems, emphasizing continuous, at-home data collection and timely interventions, extending care beyond traditional clinics.
Cadence was founded in 2020 by Chris Altchek and Kareem Zaki. They recognized a critical need for scalable, effective remote care in chronic illness management. Altchek, a technologist, and Zaki, a venture capitalist, combined their expertise to build a platform redefining care. Their insight focused on enabling continuous, personalized patient engagement.
Cadence partners with health systems, deploying solutions for patients with chronic conditions. The platform empowers providers to offer ongoing oversight and tailored support, improving patient well-being and reducing hospitalizations. Cadence’s vision is to establish a new standard in proactive, technology-enabled chronic care, making high-quality management widely accessible.
Cadence Healthcare Ventures has 3 tracked investments across 3 companies. The latest tracked deal is $18.0M Series A in Conceivable Life Sciences in January 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 15, 2025 | Conceivable Life Sciences | $18.0M Series A | — | Aike HO, Atlantic Health Venture Studio, Black Opal Ventures, Future Positive Capital, Muse Capital, Scrub Capital, Stride.VC, Time BioVentures |
| Apr 1, 2024 | Nectero Medical | $96.0M Series D | Zack Scott | Alumni Ventures, Amity Ventures, Ehukai Investments, Norwest Venture Partners, Origin Ventures, S3 Ventures, Trucks Venture Capital, Aphelion Capital, Alan Davis, Boston Scientific |
| Feb 1, 2022 | Koya Medical | $26.0M Series B | JOE Biller, CFA | 5AM Ventures, Arboretum Ventures, F Prime Capital, HealthQuest Capital, Telegraph Hill Partners, Asahi Kasei Ventures, Scientific Health Development |